MJP Similarly have been buying regularly for 7 plus years and have never sold and dont intend to. Re the value at the end of the year the Immupel technology must surely be worth more than 2 cents on its own even if Parkinson application was not succesful. So I see far less down side risk.... but the potential upside ......pick your number.!!
Hope to hear that phase 3 6 patients given go ahead imminently by Medical board and agree NZ Trader it would be timely to get an update on the original 4 trial patients and of course to hear from Carol again would be terrific . However I also would understand why she may not want herself in public domain again.
Pretty exciting this next set of 6 patients with 4 of them receiving a triple dose and to both sides of the rain. Appreciate more may not always be better but the results will be intriuging.!
- Forums
- ASX - By Stock
- 1AI
- Final, Group 3, Phase II Trials
Final, Group 3, Phase II Trials, page-3
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $16.87M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $15.87K | 1.587M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4546120 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1369 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4546120 | 0.009 |
9 | 3559181 | 0.008 |
7 | 6280009 | 0.007 |
6 | 2493750 | 0.006 |
4 | 2100000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 1369 | 1 |
0.011 | 1874932 | 12 |
0.012 | 2013968 | 7 |
0.013 | 854768 | 3 |
0.014 | 668331 | 4 |
Last trade - 13.54pm 02/07/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |